300702.SZ
天宇股份
SZSE · Healthcare · C 制造业 · CN
CNY 21.48
−2.50%Year over year
Reported trailing growth
- Revenue
- +15.3%
- EBITDA
- —
- EBIT
- +8.0%
- EPS
- -7.4%
- Free cash flow
- +143.0%
- Operating cash flow
- +125.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.7%
- EBITDA
- +54.1%
- EBIT
- +56.7%
- Net income
- +126.0%
- EPS
- +126.4%
- Free cash flow
- -34.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026